Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07122479 · ClinicalTrials.gov registry record · NA
Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients
A NA study of Acute Leukemia, sponsored by Northwell Health.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT07122479 is a NA study of Acute Leukemia that is active but no longer recruiting, run by Northwell Health. The registered enrollment target is 50 participants, below the 462-participant average among 37 other Acute Leukemia trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT07122479, a NA study of Acute Leukemia, is active but no longer recruiting, sponsored by Northwell Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to decrease the incidence of hospital acquired deconditioning (HAD) and to help standardize daily physical exercise monitoring in acute leukemia patients with anticipated prolonged duration of hospital stay. The investigators hypothesize that implementing a patient-reported adherence log of their recommended standard daily set of exercises will help reduce proportion of hospital acquired deconditioning in acute leukemia patients. The investigators also hypothesize that less adherent patients will have more inpatient hospital related events and decreased health related quality of life.
Conditions Studied
Interventions
- OTHER Three-Pronged Approach to Reduce Hospital Acquired Deconditioning
Study Locations (2)
New York
- North Shore University Hospital (NSUH) - Manhasset
- Zuckerberg Cancer Center - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-10-27 |
| Est. Completion | 2025-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07122479
The ClinicalTrials.gov registry entry for NCT07122479 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 462-participant average among 37 other Acute Leukemia trials with a reported enrollment target (89% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Leukemia appearing as the primary indexed condition, and to 1 intervention - of which Three-Pronged Approach to Reduce Hospital Acquired Deconditioning is the first listed.
NCT07122479 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07122479 about?
NCT07122479 is a clinical study titled "Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients". This study aims to decrease the incidence of hospital acquired deconditioning (HAD) and to help standardize daily physical exercise monitoring in acute leukemia patients with anticipated prolonged duration of hospital stay. The investigators hypothesize that implementing a patient-reported adherence...
What is the current status of trial NCT07122479?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-10-27. Estimated completion is 2025-08.
What conditions does trial NCT07122479 study?
This clinical trial studies the following conditions: Acute Leukemia.
What interventions are being tested in trial NCT07122479?
The interventions under investigation include: Three-Pronged Approach to Reduce Hospital Acquired Deconditioning (OTHER).
Who is sponsoring clinical trial NCT07122479?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07122479 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)
RECRUITING · NA
-
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
RECRUITING · NA
-
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
RECRUITING · NA
-
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors
ACTIVE NOT RECRUITING · NA
-
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.